Bio Green Med gets Nasdaq bid-price notice; 180 days to April 27, 2027 to top $1.00

Bio Green Med Solution, Inc.

Nasdaq notice Oct 29, 2026: BGMS bid below $1.00 for 30 straight business days, breaching Listing Rule 5550(a)(2).
180-day grace period runs to April 27, 2027; compliance requires 10 consecutive closes at or above $1.00.
Company cites a reverse split of 1:4 to 1:16, subject to stockholder approval, as a potential remedy tied to the FNRG deal.
June 4, 2026 BCA with Malaysia's Future NRG Sdn. Bhd. would make FNRG a wholly owned subsidiary via share exchange.
No immediate effect on trading; S-4 proxy/prospectus effective Oct 8, 2026; signed by CEO Datuk Dr. Doris Wong Sing Ee.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.